Peptris is an AI/ML company with a vision to enhance drug discovery efficiency and improve health. We are developing a machine learning platform to predict small molecule-protein and protein-protein interactions to discover small molecule/antibody/protein based therapies. The platform can predict interactions for 100 million of assays in a day with accuracy rivaling a wet lab experiment.